MDS Laboratory Services, part of MDS Inc., is the largest provider of diagnostic services in Canada. MDS and Myriad Genetic Laboratories entered an exclusive partnership in 2000 to provide genetic testing services in Canada to assess an individual's risk of developing breast, ovarian, colorectal or uterine cancer based on detection of disease causing mutations in the BRCA1, BRCA2, MLH1, or MSH2 genes.
Additional information regarding testing can be obtained by contacting:
Customer Service <AEWojcik@mdsintl.com>
www.mdsdx.com
